Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.

NCT02279615 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder
Benign Prostatic Hyperplasia

Interventions

DRUG: Mirabegron
DRUG: Tamsulosin

Sponsor

St. Joseph's Healthcare Hamilton